What Is The Present Market Size Of The Genomics Personalized Health Market, And At What Annual Growth Rate Is It Expanding?
The genomics personalized health market size has grown rapidly in recent years. It will grow from $15.97 billion in 2024 to $18.5 billion in 2025 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to advancements in genomics research, government funding, and support, a rise in chronic diseases, technological innovations, pharmaceutical industry investment, collaborations, and partnerships.
The genomics personalized health market size is expected to see rapid growth in the next few years. It will grow to $32.49 billion in 2029 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to increasing healthcare investments, growing adoption of genomics technologies, expanding applications of personalized medicine, rising prevalence of genetic disorders, expansion of biobanks, and increasing prevalence of chronic diseases. Major trends in the forecast period include integration with wearable technology, growth of direct-to-consumer genetic testing, advancements in CRISPR and gene editing, integration of genomics with digital health, and expansion of precision medicine initiatives.
Claim Your Free Report Sample Today:
What Fundamental Drivers Are Expected To Boost The Genomics Personalized Health Market Throughout The Forecast Period?
The growing demand for personalized medicine is expected to propel the growth of the genomics personalized health market going forward. Personalized medicine, also known as precision medicine, is an approach to healthcare that tailors medical treatment and practices to the individual characteristics of each patient. The demand for personalized medicine is due to a shift toward preventive healthcare, improved treatment outcomes, patient empowerment and engagement, economic benefits, and rising incidence of chronic and complex diseases. Genomics personalized health significantly advances personalized medicine by leveraging individual genetic information to tailor medical care, from prevention and diagnosis to treatment and monitoring. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the Food and Drug Administration (FDA) approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the growing demand for personalized medicine is driving the demand for genomics personalized health market.
What Are The Key Segmentation Components That Define The Structure Of The Genomics Personalized Health Market?
The genomics personalized healthmarket covered in this report is segmented –
1) By Test Type: Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, Other Test Type
2) By Technology: NGS platforms, RT-PCR, Microarray, Genetic Analyzers
3) By End User: Academic Research Institutes, Diagnostic Centers, Other End Users
Subsegments:
1) Oncology Testing: Cancer Genomic Profiling, Liquid Biopsy Testing, Tumor Mutational Burden Testing, Genetic Biomarker Testing
2) Infectious Disease Testing: PCR-Based Tests, Next-Generation Sequencing (NGS) Tests, Microbial Genomic Profiling
3) Orphan Disease Testing: Genetic Screening For Rare Diseases, Genetic Testing For Inherited Disorders, Targeted Gene Panels
4) Autoimmune Disease Testing: Genetic Screening For Autoimmune Conditions, Immune System Gene Profiling, HLA Typing Tests
5) Obstetrics Testing: Non-Invasive Prenatal Testing (NIPT), Genetic Screening For Birth Defects, Carrier Screening Tests
6) Other Test Type: Cardiovascular Genetic Testing, Neurological Disease Testing, Metabolic Disease Genetic Testing
Which Rising Trends Are Anticipated To Influence The Future Trajectory Of The Genomics Personalized Health Market?
Major companies operating in the genomics personalized health market are focused on developing innovative products, such as for cloud-based software designed for tertiary analysis of clinical next-generation sequencing (NGS) data., to gain a competitive edge in the market. Clinical next-generation sequencing (NGS) data refers to the genetic information generated from sequencing technologies that allow for high-throughput, detailed analysis of DNA or RNA samples in a clinical setting.. For instance, in March 2023, Illumina, a US-based biotechnology company specializing in DNA sequencing and array-based technologies, launched Connected Insights, a cloud-based software designed for tertiary analysis of clinical next-generation sequencing (NGS) data. This platform aims to streamline the interpretation and reporting processes, particularly for oncology applications, and supports comprehensive genomic profiling. Connected Insights integrates various third-party knowledge bases, facilitating precise data analysis and enhancing the efficiency of precision care initiatives
Who Are The Standout Companies Known For Innovation In The Genomics Personalized Health Market?
Major companies operating in the genomics personalized health market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Quest Diagnostics, Agilent Technologies Inc., Lonza Group, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V, Natera Inc., Adaptive Biotechnologies Corporation, Myriad Genetics Inc., NanoString Technologies Inc., Pacific Biosciences of California Inc., Personalis Inc., DNA Genotek Inc., Twist Bioscience Corporation, GRAIL Inc., Eastern Biotech and Life Sciences, INVITAE Corporation, Genetic Technologies Limited, XCode Life Sciences Private Limited, Biome Inc., BGI Genomics Co. Ltd.
Get Your In-Depth Genomics Personalized Health Market Report Now:
Which Geographical Region Is Projected To Lead The Genomics Personalized Health Market Throughout The Forecast Period?
North America was the largest region in the personalized health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics personalized health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment